Anamaría Olarte-Díaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anamaría Olarte-Díaz has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- David Felipe Alfonso-Cedeño
Semillero de Investigación en Neurociencias, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia
1 shared publication - Felipe Duarte-Zambrano
Universidad Nacional de Colombia, Sede Bogotá, Facultad de Medicina, Departamento de Ciencias Fisiológicas, División de Lípidos y Diabetes, Bogotá, Colombia
1 shared publication - Gonzalo Arboleda
Departamento de Patologia, Instituto de Genetica, Universidad Nacional de Colombia, Carrera 30 No. 45-03, Ciudad Universitaria, Bogota, Colombia
1 shared publication - Humberto Arboleda
Semillero de Investigación en Neurociencias, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia
1 shared publication - Jorge Andrés Barrero
Laboratory of Molecular Metabolism, The Rockefeller University, New York, USA
1 shared publication - Luis Alejandro Rodríguez-Vanegas
Semillero de Investigación en Neurociencias, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia
1 shared publication
Latest Publications
- Open Access
- 3 April 2025
- Published by Springer Nature in neurogenetics
- Vol. 26 (1) , 1-16
Genetic variants associated with idiopathic Parkinson’s disease in Latin America: A systematic review
Idiopathic Parkinson’s disease (PD) constitutes a complex trait influenced by genetic, environmental, and lifestyle factors, with an estimated heritability of nearly 30%. However, a large proportion of the heritable variation linked to PD remains uncertain, partly due to ancestral bias. Expanding research into Hispanic populations can contribute to address this gap. To review the evidence of genetic variants associated with idiopathic PD in Latin America. A PRISMA-compliant systematic review was conducted in MEDLINE, EMBASE and LILACS, compiling studies published up to February 7, 2025. Nineteen case–control studies were included. Two hypothesis-free studies identified rs525496 near H2BW1 as a protective factor and rs356182 in SNCA as a risk factor through XWAS and GWAS, respectively. Seventeen hypothesis-driven studies examined over three hundred variants, identifying nineteen genetic markers; risk factors included one INDEL in NR4A2 , CNV burdens in PRKN , SNCA , and PLA2G6 , along with fourteen variants in six loci including GBA , APOEε4 , MTHFR , LRRK2 , and SNCA . Three SNPs in the PICALM , ALDH1A1 , and APOE-ε3 loci were identified as protective factors. Additionally, six SNCA variant haplotypes appear to increase PD risk, while two NR4A2 INDELs haplotypes showed mixed effects. This review summarized genetic loci associated with idiopathic PD in Latin American populations evidencing an overlap with European findings as well as novel loci, although awaiting replication and validation. These observations contribute to the understanding of genetic configuration of the disease and highlight the need for further genomic research in underrepresented groups that include local ancestry analysis within admixed cohorts to guide development of personalized treatments and population-specific interventions.
- 3 April 2025
- Published by Springer Nature in neurogenetics
- Vol. 26 (1) , 1-16
Open AccessGenetic variants associated with idiopathic Parkinson’s disease in Latin America: A systematic review
Idiopathic Parkinson’s disease (PD) constitutes a complex trait influenced by genetic, environmental, and lifestyle factors, with an estimated heritability of nearly 30%. However, a large proportion of the heritable variation linked to PD remains uncertain, partly due to ancestral bias. Expanding research into Hispanic populations can contribute to address this gap. To review the evidence of genetic variants associated with idiopathic PD in Latin America. A PRISMA-compliant systematic review was conducted in MEDLINE, EMBASE and LILACS, compiling studies published up to February 7, 2025. Nineteen case–control studies were included. Two hypothesis-free studies identified rs525496 near H2BW1 as a protective factor and rs356182 in SNCA as a risk factor through XWAS and GWAS, respectively. Seventeen hypothesis-driven studies examined over three hundred variants, identifying nineteen genetic markers; risk factors included one INDEL in NR4A2 , CNV burdens in PRKN , SNCA , and PLA2G6 , along with fourteen variants in six loci including GBA , APOEε4 , MTHFR , LRRK2 , and SNCA . Three SNPs in the PICALM , ALDH1A1 , and APOE-ε3 loci were identified as protective factors. Additionally, six SNCA variant haplotypes appear to increase PD risk, while two NR4A2 INDELs haplotypes showed mixed effects. This review summarized genetic loci associated with idiopathic PD in Latin American populations evidencing an overlap with European findings as well as novel loci, although awaiting replication and validation. These observations contribute to the understanding of genetic configuration of the disease and highlight the need for further genomic research in underrepresented groups that include local ancestry analysis within admixed cohorts to guide development of personalized treatments and population-specific interventions.